About EXOCULAR DX INC
ExOcular DX Inc is developing blood-based multiplex tests that measure eye disease-specific biomarkers isolated from exosomes to aid in the early diagnosis, prognosis, and treatment monitoring of severe eye diseases such as diabetic retinopathy and age-related macular degeneration.
Exosome-based multiplex biomarker panels for severe eye diseasesDevelopment of blood-based tests for early diagnosis and treatment monitoringGeneration of quantitative Disease Severity Scores using analysis algorithmsIdentification of disease-specific biomarkers for diagnostic, prognostic, and monitoring purposes
Is this your company?
Claim EXOCULAR DX INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim EXOCULAR DX INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.